Skip to main content

Clinical trial IJB_2745

Phase 1/2a study to evaluate the safety, activity, and pharmacokinetics of escalating doses of GNS561 in patients with primary liver cancer

Cancers
Organ liver
Trial status Trial open for recruitment
Investigator
Trial type
Prospective interventional
Phase Trial phase 1/2
Academic trial Non
Sponsor Genoscience Pharma
EudraCT Identifier 2017-003585-27
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03316222
Inclusion criteria RECIST v1.1
Last update